Advances in understanding the pulmonary infiltration in acute promyelocytic leukaemia

British Journal of Haematology

Volumn 151, Issue 3, 2010, Pages 209-220

  Luesink, Maaike ^a   Jansen, Joop H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute promyelocytic leukaemia; Adhesion molecules; Chemokines; Corticosteroids; Differentiation therapy; Integrins

Indexed keywords

ALPHA4 INTEGRIN; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; CCL1 CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; CORTICOSTEROID; DEXAMETHASONE; GELATINASE A; IDARUBICIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; NEUTROPHIL COLLAGENASE; PROTEINASE; RETINOIC ACID; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; CHEMOKINE;

ARTICLE; ARTIFICIAL VENTILATION; CELL ADHESION; CLINICAL FEATURE; CYTOKINE PRODUCTION; DIFFERENTIATION SYNDROME; DRUG EFFICACY; ENDOTHELIUM; HIGH RISK PATIENT; HUMAN; IMMUNOPATHOGENESIS; INCIDENCE; LUNG EDEMA; LUNG INFILTRATE; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; PROMYELOCYTIC LEUKEMIA; RETINOIC ACID SYNDROME; RISK REDUCTION; TREATMENT RESPONSE; BIOLOGICAL MODEL; CANCER INVASION; CELL DIFFERENTIATION; DRUG EFFECT; LUNG; PATHOLOGY; PHYSIOLOGY; REVIEW; SYNDROME;

ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL DIFFERENTIATION; CHEMOKINES; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUKEMIC INFILTRATION; LUNG; MODELS, BIOLOGICAL; SYNDROME;

EID: 79952049937     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08325.x     Document Type: Article

References (95)

1. Asou, N., Adachi, K., Tamura, J., Kanamaru, A., Kageyama, S., Hiraoka, A., Omoto, E., Akiyama, H., Tsubaki, K., Saito, K., Kuriyama, K., Oh, H., Kitano, K., Miyawaki, S., Takeyama, K., Yamada, O., Nishikawa, K., Takahashi, M., Matsuda, S., Ohtake, S., Suzushima, H., Emi, N. & Ohno, R. (1998) Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-transretinoic acid and chemotherapy. Japan Adult Leukemia Study Group. Journal of Clinical Oncology, 16, 78-85.
2. Asou, N., Kishimoto, Y., Kiyoi, H., Okada, M., Kawai, Y., Tsuzuki, M., Horikawa, K., Matsuda, M., Shinagawa, K., Kobayashi, T., Ohtake, S., Nishimura, M., Takahashi, M., Yagasaki, F., Takeshita, A., Kimura, Y., Iwanaga, M., Naoe, T. & Ohno, R. (2007) A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARalpha transcript after consolidation therapy: the Japan Adult Leukemia Study Group (JALSG) APL97 study. Blood, 110, 59-66.
3. Avvisati, G. (2009) CCL2/CCR2: push/pull for migration. Blood, 114, 5411-5412.
4. Azoulay, E., Fieux, F., Moreau, D., Thiery, G., Rousselot, P., Parrot, A., Le Gall, J.R., Dombret, H. & Schlemmer, B. (2003) Acute monocytic leukemia presenting as acute respiratory failure. American Journal of Respiratory and Critical Care Medicine, 167, 1329-1333.
5. Bacon, K., Baggiolini, M., Broxmeyer, H., Horuk, R., Lindley, I., Mantovani, A., Maysushima, K., Murphy, P., Nomiyama, H., Oppenheim, J., Rot, A., Schall, T., Tsang, M., Thorpe, R., Van Damme, J., Wadhwa, M., Yoshie, O., Zlotnik, A. & Zoon, K. (2002) Chemokine/chemokine receptor nomenclature. Journal of Interferon & Cytokine Research, 22, 1067-1068.
6. Bao, Z., Ye, Q., Gong, W., Xiang, Y. & Wan, H. (2010) Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury. International Immunopharmacology, 10, 259-263.
7. Behringer, D., Schaufler, J., Kresin, V., Lubbert, M. & Lindemann, A. (2001) Differentiation associated modulation of the cytokine and chemokine expression pattern in human myeloid cell lines. Leukemia Research, 25, 141-149.
8. Bertini, R., Allegretti, M., Bizzarri, C., Moriconi, A., Locati, M., Zampella, G., Cervellera, M.N., Di Cioccio, V., Cesta, M.C., Galliera, E., Martinez, F.O., Di Bitondo R., Troiani, G., Sabbatini, V., D'Anniballe, G., Anacardio, R., Cutrin, J.C., Cavalieri, B., Mainiero, F., Strippoli, R., Villa, P., Di Girolamo M., Martin, F., Gentile, M., Santoni, A., Corda, D., Poli, G., Mantovani, A., Ghezzi, P. & Colotta, F. (2004) Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. Proceedings of the National Academy of Sciences of the United States of America, 101, 11791-11796.
9. Bhatia, M. & Moochhala, S. (2004) Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. The Journal of Pathology, 202, 145-156.
10. de Botton, S., Dombret, H., Sanz, M., San Miguel, J., Caillot, D., Zittoun, R., Gardembas, M., Stamatoulas, A., Conde, E., Guerci, A., Gardin, C., Geiser, K., Cony Makhoul, D., Reman, O., de la Serna, J., Lefrere, F., Chomienne, C., Chastang, C., Degos, L. & Fenaux, P. (1998) Incidence, clinical features, and outcome of all transretinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood, 92, 2712-2718.
11. de Botton, S., Chevret, S., Coiteux, V., Dombret, H., Sanz, M., San, M.J., Caillot, D., Vekhoff, A., Gardembas, M., Stamatoulas, A., Conde, E., Guerci, A., Gardin, C., Fey, M., Cony, M.D., Reman, O., de la Serna, J., Lefrere, F., Chomienne, C., Degos, L. & Fenaux, P. (2003) Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial. Leukemia, 17, 339-342.
12. Breccia, M., Latagliata, R., Carmosino, I., Cannella, L., Diverio, D., Guarini, A., De Propris, M.S., Petti, M.C., Avvisati, G., Cimino, G., Mandelli, F. & Lo-Coco, F. (2008) Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin. Haematologica, 93, 1918-1920.
13. Brown, D.C., Tsuji, H. & Larson, R.S. (1999) All-trans retinoic acid regulates adhesion mechanism and transmigration of the acute promyelocytic leukaemia cell line NB-4 under physiologic flow. British Journal of Haematology, 107, 86-98.
14. Burger, J.A. & Peled, A. (2009) CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia, 23, 43-52.
15. Burn, T.C., Petrovick, M.S., Hohaus, S., Rollins, B.J. & Tenen, D.G. (1994) Monocyte chemoattractant protein-1 gene is expressed in activated neutrophils and retinoic acid-induced human myeloid cell lines. Blood, 84, 2776-2783.
16. Busch-Petersen, J. (2006) Small molecule antagonists of the CXCR2 and CXCR1 chemokine receptors as therapeutic agents for the treatment of inflammatory diseases. Current Topics in Medicinal Chemistry, 6, 1345-1352.
17. van Buul, J.D. & Hordijk, P.L. (2004) Signaling in leukocyte transendothelial migration. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 824-833.
18. Camacho, L.H., Soignet, S.L., Chanel, S., Ho, R., Heller, G., Scheinberg, D.A., Ellison, R. & Warrell, Jr, R.P. (2000) Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide. Journal of Clinical Oncology, 18, 2620-2625.
19. Chang, M.M., Harper, R., Hyde, D.M. & Wu, R. (2000) A novel mechanism of retinoic acid-enhanced interleukin-8 gene expression in airway epithelium. American Journal of Respiratory Cell and Molecular Biology, 22, 502-510.
20. Chapman, R.W., Minnicozzi, M., Celly, C.S., Phillips, J.E., Kung, T.T., Hipkin, R.W., Fan, X., Rindgen, D., Deno, G., Bond, R., Gonsiorek, W., Billah, M.M., Fine, J.S. & Hey, J.A. (2007) A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation. The Journal of Pharmacology and Experimental Therapeutics, 322, 486-493.
21. Cignetti, A., Vallario, A., Roato, I., Circosta, P., Strola, G., Scielzo, C., Allione, B., Garetto, L., Caligaris-Cappio, F. & Ghia, P. (2003) The characterization of chemokine production and chemokine receptor expression reveals possible functional cross-talks in AML blasts with monocytic differentiation. Experimental Hematology, 31, 495-503.
22. Cunha De Santis, G., Tamarozzi, M.B., Sousa, R.B., Moreno, S.E., Secco, D., Garcia, A.B., Lima, A.S., Faccioli, L.H., Falcao, R.P., Cunha, F.Q. & Rego, E.M. (2007) Adhesion molecules and differentiation syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia. Haematologica, 92, 1615-1622.
23. Dai, C.W., Zhang, G.S., Shen, J.K., Zheng, W.L., Pei, M.F., Xu, Y.X., Cao, Y.X., Yi, Y., Yang, J.J., Peng, H.L., Zhong, H.Y. & Li, R.J. (2009) Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients. Acta Haematologica, 121, 1-8.
24. Deshmane, S.L., Kremlev, S., Amini, S. & Sawaya, B.E. (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. Journal of Interferon & Cytokine Research, 29, 313-326.
25. Devy, L., Hollender, P., Munaut, C., Colige, A., Garnotel, R., Foidart, J.M., Noel, A. & Jeannesson, P. (2002) Matrix and serine protease expression during leukemic cell differentiation induced by aclacinomycin and all-trans-retinoic acid. Biochemical Pharmacology, 63, 179-189.
26. Dore, A.I., Santana-Lemos, B.A., Coser, V.M., Santos, F.L., Dalmazzo, L.F., Lima, A.S., Jacomo, R.H., Elias, Jr, J., Falcao, R.P., Pereira, W.V. & Rego, E.M. (2007) The association of ICAM-1 Exon 6 (E469K) but not of ICAM-1 Exon 4 (G241R) and PECAM-1 Exon 3 (L125V) polymorphisms with the development of differentiation syndrome in acute promyelocytic leukemia. Journal of Leukocyte Biology, 82, 1340-1343.
27. Elkington, P.T. & Friedland, J.S. (2006) Matrix metalloproteinases in destructive pulmonary pathology. Thorax, 61, 259-266.
28. Estey, E., Garcia-Manero, G., Ferrajoli, A., Faderl, S., Verstovsek, S., Jones, D. & Kantarjian, H. (2006) Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia. Blood, 107, 3469-3473.
29. Fenaux, P., Le Deley, M.C., Castaigne, S., Archimbaud, E., Chomienne, C., Link, H., Guerci, A., Duarte, M., Daniel, M.T. & Bowen, D. (1993) Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group. Blood, 82, 3241-3249.
30. Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., Fey, M., Rayon, C., Huguet, F., Sotto, J.J., Gardin, C., Makhoul, P.C., Travade, P., Solary, E., Fegueux, N., Bordessoule, D., Miguel, J.S., Link, H., Desablens, B., Stamatoullas, A., Deconinck, E., Maloisel, F., Castaigne, S., Preudhomme, C. & Degos, L. (1999) A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood, 94, 1192-1200.
31. Frankel, S.R., Eardley, A., Lauwers, G., Weiss, M. & Warrell, Jr, R.P. (1992) The "retinoic acid syndrome" in acute promyelocytic leukemia. Annals of Internal Medicine, 117, 292-296.
32. Gao, P., Wange, R.L., Zhang, N., Oppenheim, J.J. & Howard, O.M. (2005) Negative regulation of CXCR4-mediated chemotaxis by the lipid phosphatase activity of tumor suppressor PTEN. Blood, 106, 2619-2626.
33. Ghavamzadeh, A., Alimoghaddam, K., Ghaffari, S.H., Rostami, S., Jahani, M., Hosseini, R., Mossavi, A., Baybordi, E., Khodabadeh, A., Iravani, M., Bahar, B., Mortazavi, Y., Totonchi, M. & Aghdami, N. (2006) Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy. Annals of Oncology, 17, 131-134.
34. Hayakawa, M., Katabami, K., Wada, T., Sugano, M., Hoshino, H., Sawamura, A. & Gando, S. (2010) Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both acute respiratory distress syndrome and disseminated intravascular coagulation patients. Shock, 33, 14-18.
35. Heit, B., Robbins, S.M., Downey, C.M., Guan, Z., Colarusso, P., Miller, B.J., Jirik, F.R. & Kubes, P. (2008) PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils. Nature Immunology, 9, 743-752.
36. Horuk, R. (2009) Chemokine receptor antagonists: overcoming developmental hurdles. Nature Reviews. Drug Discovery, 8, 23-33.
37. Hsu, H.C., Tsai, W.H., Chen, P.G., Hsu, M.L., Ho, C.K. & Wang, S.Y. (1999) In vitro effect of granulocyte-colony stimulating factor and all-trans retinoic acid on the expression of inflammatory cytokines and adhesion molecules in acute promyelocytic leukemic cells. European Journal of Haematology, 63, 11-18.
38. Hu, J., Liu, Y.F., Wu, C.F., Xu, F., Shen, Z.X., Zhu, Y.M., Li, J.M., Tang, W., Zhao, W.L., Wu, W., Sun, H.P., Chen, Q.S., Chen, B., Zhou, G.B., Zelent, A., Waxman, S., Wang, Z.Y., Chen, S.J. & Chen, Z. (2009) Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 106, 3342-3347.
39. Kakihana, K., Ohashi, K., Sakai, F., Kamata, N., Hosomi, Y., Nishiwaki, M., Yokoyama, R., Kobayashi, T., Yamashita, T., Akiyama, H. & Sakamaki, H. (2009) Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation. International Journal of Hematology, 89, 118-122.
40. Kakizuka, A., Miller, Jr, W.H., Umesono, Jr, K., Warrell, Jr, R.P., Frankel, S.R., Murty, V.V., Dmitrovsky, E. & Evans, R.M. (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell, 66, 663-674.
41. Kawaguchi, A., Orba, Y., Kimura, T., Iha, H., Ogata, M., Tsuji, T., Ainai, A., Sata, T., Okamoto, T., Hall, W.W., Sawa, H. & Hasegawa, H. (2009) Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice. Blood, 114, 2961-2968.
42. Kawasaki, K., Akaike, H., Miyauchi, A. & Ouchi, K. (2006) Sivelestat relieves respiratory distress refractory to dexamethasone in all-trans retinoic acid syndrome: a report of two cases. European Journal of Haematology, 77, 448-452.
43. Koh, T.T., Colby, T.V. & Muller, N.L. (2005) Myeloid leukemias and lung involvement. Seminars in Respiratory and Critical Care Medicine, 26, 514-519.
44. Kovalski, R., Hansen-Flaschen, J., Lodato, R.F. & Pietra, G.G. (1990) Localized leukemic pulmonary infiltrates. Diagnosis by bronchos copy and resolution with therapy. Chest, 97, 674-678.
45. Lane, A.A. & Ley, T.J. (2003) Neutrophil elastase cleaves PML-RAR-alpha and is important for the development of acute promyelocytic leukemia in mice. Cell, 115, 305-318.
46. Larson, R.S., Brown, D.C. & Sklar, L.A. (1997) Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB-4 by utilization of LFA-1 and ICAM-2. Blood, 90, 2747-2756.
47. Lee, K.H., Chang, M.Y., Ahn, J.I., Yu, D.H., Jung, S.S., Choi, J.H., Noh, Y.H., Lee, Y.S. & Ahn, M.J. (2002) Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. Biochemical and Biophysical Research Communications, 296, 1125-1133.
48. Luesink, M., Pennings, J.L., Wissink, W.M., Linssen, P.C., Muus, P., Pfundt, R., de Witte, T.J., van der Reijden, B.A. & Jansen, J.H. (2009) Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome. Blood, 114, 5512-5521.
49. Mandelli, F., Diverio, D., Avvisati, G., Luciano, A., Barbui, T., Bernasconi, C., Broccia, G., Cerri, R., Falda, M., Fioritoni, G., Leoni, F., Liso, V., Petti, M.C., Rodeghiero, F., Saglio, G., Vegna, M.L., Visani, G., Jehn, U., Willemze, R., Muus, P., Pelicci, P.G., Biondi, A. & Lo-Coco, F. (1997) Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Blood, 90, 1014-1021.
50. Marchetti, M., Falanga, A., Giovanelli, S., Oldani, E. & Barbui, T. (1996) All-trans-retinoic acid increases adhesion to endothelium of the human promyelocytic leukaemia cell line NB4. British Journal of Haematology, 93, 360-366.
51. Martens, J.H., Brinkman, A.B., Simmer, F., Francoijs, K.J., Nebbioso, A., Ferrara, F., Altucci, L. & Stunnenberg, H.G. (2010) PML-RAR-alpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia. Cancer Cell, 17, 173-185.
52. Mathews, V., George, B., Lakshmi, K.M., Viswabandya, A., Bajel, A., Balasubramanian, P., Shaji, R.V., Srivastava, V.M., Srivastava, A. & Chandy, M. (2006) Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood, 107, 2627-2632.
53. Melgarejo, E., Medina, M.A., Sanchez-Jimenez, F. & Urdiales, J.L. (2009) Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. The International Journal of Biochemistry & Cell Biology, 41, 998-1001.
54. Montesinos, P., Bergua, J.M., Vellenga, E., Rayon, C., Parody, R., de la Serna, J., Leon, A., Esteve, J., Milone, G., Deben, G., Rivas, C., Gonzalez, M., Tormo, M., Diaz-Mediavilla, J., Gonzalez, J.D., Negri, S., Amutio, E., Brunet, S., Lowenberg, B. & Sanz, M.A. (2008) Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-transretinoic acid and anthracycline chemotherapy: characteristics, outcome and prognostic factors. Blood, 113, 775-783.
55. Moraes, T.J., Chow, C.W. & Downey, G.P. (2003) Proteases and lung injury. Critical Care Medicine, 31, S189-S194.
56. Mulabecirovic, A., Gaulhofer, P., Auner, H.W., Popper, H., Krause, R., Hesse, C. & Sill, H. (2004) Pulmonary infiltrates in patients with haematologic malignancies: transbronchial lung biopsy increases the diagnostic yield with respect to neoplastic infiltrates and toxic pneumonitis. Annals of Hematology, 83, 420-422.
57. Ninomiya, M., Kiyoi, H., Ito, M., Hirose, Y., Ito, M. & Naoe, T. (2004) Retinoic acid syndrome in NOD/scid mice induced by injecting an acute promyelocytic leukemia cell line. Leukemia, 18, 442-448.
58. Potenza, L., Luppi, M., Morselli, M., Tonelli, S., D'Apollo, N., Facchini, L., Torricelli, P., Tazzioli, G., Saviola, A., Bresciani, P., Longo, G. & Torelli, G. (2003) Leukaemic pulmonary infiltrates in adult acute myeloid leukaemia: a high-resolution computerized tomography study. British Journal of Haematology, 120, 1058-1061.
59. Puneet, P., Moochhala, S. & Bhatia, M. (2005) Chemokines in acute respiratory distress syndrome. American Journal of Physiology. Lung Cellular and Molecular Physiology, 288, L3-L15.
60. Ravandi, F., Estey, E., Jones, D., Faderl, S., O'Brien, S., Fiorentino, J., Pierce, S., Blamble, D., Estrov, Z., Wierda, W., Ferrajoli, A., Verstovsek, S., Garcia-Manero, G., Cortes, J. & Kantarjian, H. (2009) Effective treatment of acute promyelocytic leukemia with all-transretinoic acid, arsenic trioxide, and gemtuzumab ozogamicin. Journal of Clinical Oncology, 27, 504-510.
61. Rose, Jr, C.E., Sung, S.S. & Fu, S.M. (2003) Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation, 10, 273-288.
62. Sanz, M.A., Martin, G., Gonzalez, M., Leon, A., Rayon, C., Rivas, C., Colomer, D., Amutio, E., Capote, F.J., Milone, G.A., de la Serna, J., Roman, J., Barragan, E., Bergua, J., Escoda, L., Parody, R., Negri, S., Calasanz, M.J. & Bolufer, P. (2004) Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthra-cycline monochemotherapy: a multicenter study by the PETHEMA group. Blood, 103, 1237-1243.
63. Sanz, M.A., Montesinos, P., Vellenga, E., Rayon, C., de la Serna, J., Parody, R., Bergua, J.M., Leon, A., Negri, S., Gonzalez, M., Rivas, C., Esteve, J., Milone, G., Gonzalez, J.D., Amutio, E., Brunet, S., Garcia-Larana, J., Colomer, D., Calasanz, M.J., Chillon, C., Barragan, E., Bolufer, P. & Lowenberg, B. (2008) Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group. Blood, 112, 3130-3134.
64. Sanz, M.A., Grimwade, D., Tallman, M.S., Lowenberg, B., Fenaux, P., Estey, E.H., Naoe, T., Lengfelder, E., Buchner, T., Dohner, H., Burnett, A.K. & Lo-Coco, F. (2009) Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, 113, 1875-1891.
65. Sarraj, B., Massberg, S., Li, Y., Kasorn, A., Subramanian, K., Loison, F., Silberstein, L.E., von Adrian, U. & Luo, H.R. (2009) Myeloid-specific deletion of tumor suppressor PTEN augments neutrophil transendothelial migration during inflammation. Journal of Immunology, 182, 7190-7200.
66. de la Serna, J., Montesinos, P., Vellenga, E., Rayon, C., Parody, R., Leon, A., Esteve, J., Bergua, J.M., Milone, G., Deben, G., Rivas, C., Gonzalez, M., Tormo, M., Diaz-Mediavilla, J., Gonzalez, J.D., Negri, S., Amutio, E., Brunet, S., Lowenberg, B. & Sanz, M.A. (2008) Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood, 111, 3395-3402.
67. Shen, Z.X., Chen, G.Q., Ni, J.H., Li, X.S., Xiong, S.M., Qiu, Q.Y., Zhu, J., Tang, W., Sun, G.L., Yang, K.Q., Chen, Y., Zhou, L., Fang, Z.W., Wang, Y.T., Ma, J., Zhang, P., Zhang, T.D., Chen, S.J., Chen, Z. & Wang, Z.Y. (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood, 89, 3354-3360.
68. Shen, Z.X., Shi, Z.Z., Fang, J., Gu, B.W., Li, J.M., Zhu, Y.M., Shi, J.Y., Zheng, P.Z., Yan, H., Liu, Y.F., Chen, Y., Shen, Y., Wu, W., Tang, W., Waxman, S., de The, H., Wang, Z.Y., Chen, S.J. & Chen, Z. (2004) All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 101, 5328-5335.
69. Shibakura, M., Niiya, K., Kiguchi, T., Shinagawa, K., Ishimaru, F., Ikeda, K., Namba, M., Nakata, Y., Harada, M. & Tanimoto, M. (2002) Simultaneous induction of matrix metalloproteinase-9 and interleukin 8 by all-trans retinoic acid in human PL-21 and NB4 myeloid leukaemia cells. British Journal of Haematology, 118, 419-425.
70. Shibakura, M., Niiya, K., Niiya, M., Asaumi, N., Yoshida, C., Nakata, Y. & Tanimoto, M. (2005) Induction of CXC and CC chemokines by all-trans retinoic acid in acute promyelocytic leukemia cells. Leukemia Research, 29, 755-759.
71. Soignet, S.L., Frankel, S.R., Douer, D., Tallman, M.S., Kantarjian, H., Calleja, E., Stone, R.M., Kalaycio, M., Scheinberg, D.A., Steinherz, P., Sievers, E.L., Coutre, S., Dahlberg, S., Ellison, R. & Warrell, Jr, R.P. (2001) United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. Journal of Clinical Oncology, 19, 3852-3860.
72. Song, M.S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J. & Pandolfi, P.P. (2008) The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature, 455, 813-817.
73. Springer, T.A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76, 301-314.
74. Subramanian, K.K., Jia, Y., Zhu, D., Simms, B.T., Jo, H., Hattori, H., You, J., Mizgerd, J.P. & Luo, H.R. (2007) Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions. Blood, 109, 4028-4037.
75. Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Ogden, A., Shepherd, L., Rowe, J.M., Francois, C., Larson, R.S. & Wiernik, P.H. (2000) Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood, 95, 90-95.
76. Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Woods, W.G., Ogden, A., Weinstein, H., Shepherd, L., Willman, C., Bloomfield, C.D., Rowe, J.M. & Wiernik, P.H. (2002) All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood, 100, 4298-4302.
77. Tamakuma, S., Ogawa, M., Aikawa, N., Kubota, T., Hirasawa, H., Ishizaka, A., Taenaka, N., Hamada, C., Matsuoka, S. & Abiru, T. (2004) Relationship between neutrophil elastase and acute lung injury in humans. Pulmonary Pharmacology & Therapeutics, 17, 271-279.
78. Taraboletti, G., Borsotti, P., Chirivi, R.G., Vergani, V., Falanga, A., Barbui, T., Giavazzi, R. & Rambaldi, A. (1997) Effect of all trans-retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cells. International Journal of Cancer, 70, 72-77.
79. de The, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L. & Dejean, A. (1991) The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell, 66, 675-684.
80. Tsai, W.H., Hsu, H.C., Lin, C.C., Ho, C.K. & Kou, Y.R. (2007) Role of interleukin-8 and growth-regulated oncogene-alpha in the chemotactic migration of all-trans retinoic acid-treated promyelocytic leukemic cells toward alveolar epithelial cells. Critical Care Medicine, 35, 879-885.
81. Tsai, W.H., Shih, C.H., Lin, C.C., Ho, C.K., Hsu, F.C. & Hsu, H.C. (2008) Monocyte chemotactic protein-1 in the migration of differentiated leukaemic cells toward alveolar epithelial cells. The European Respiratory Journal, 31, 957-962.
82. Vahdat, L., Maslak, P., Miller, Jr, W.H., Eardley, A., Heller, G., Scheinberg, D.A. & Warrell, Jr, R.P. (1994) Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood, 84, 3843-3849.
83. Viola, A. & Luster, A.D. (2008) Chemokines and their receptors: drug targets in immunity and inflammation. Annual Review of Pharmacology and Toxicology, 48, 171-197.
84. Walters, I., Austin, C., Austin, R., Bonnert, R., Cage, P., Christie, M., Ebden, M., Gardiner, S., Grahames, C., Hill, S., Hunt, F., Jewell, R., Lewis, S., Martin, I., David, N. & David, R. (2008) Evaluation of a series of bicyclic CXCR2 antagonists. Bioorganic & Medicinal Chemistry Letters, 18, 798-803.
85. Wang, Z.Y. & Chen, Z. (2008) Acute promyelocytic leukemia: from highly fatal to highly curable. Blood, 111, 2505-2515.
86. Wang, G., Li, W., Cui, J., Gao, S., Yao, C., Jiang, Z., Song, Y., Yuan, C.J., Yang, Y., Liu, Z. & Cai, L. (2004) An efficient therapeutic approach to patients with acute promyelocytic leukemia using a combination of arsenic trioxide with low-dose all-trans retinoic acid. Hematological Oncology, 22, 63-71.
87. Warrell, Jr, R.P., Frankel, S.R., Miller, Jr, W.H., Scheinberg, D.A., Itri, L.M., Hittelman, W.N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., Gabrilove, J., Gordon, M.S. & Dmitrovsky, E. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). New England Journal of Medicine, 324, 1385-1393.
88. Warrell, Jr, R.P., de The, H., Wang, Z.Y. & Degos, L. (1993) Acute promyelocytic leukemia. New England Journal of Medicine, 329, 177-189.
89. Wu, Y.K., Huang, Y.C., Huang, S.F., Huang, C.C. & Tsai, Y.H. (2008) Acute respiratory distress syndrome caused by leukemic infiltration of the lung. Journal of the Formosan Medical Association, 107, 419-423.
90. Xia, M. & Sui, Z. (2009) Recent developments in CCR2 antagonists. Expert Opinion on Therapeutic Patents, 19, 295-303.
91. Yang, D., Tong, L., Wang, D., Wang, Y., Wang, X. & Bai, C. (2010) Roles of CC chemokine receptors (CCRs) on lipopolysaccharide-induced acute lung injury. Respiratory Physiology & Neurobiology, 170, 253-259.
92. Zang, C., Liu, H., Ries, C., Ismair, M.G. & Petrides, P.E. (2000) Enhanced migration of the acute promyelocytic leukemia cell line NB4 under in vitro conditions during short-term all-trans-retinoic acid treatment. Journal of Cancer Research and Clinical Oncology, 126, 33-40.
93. Zeiher, B.G., Matsuoka, S., Kawabata, K. & Repine, J.E. (2002) Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics. Critical Care Medicine, 30, S281-S287.
94. Zeiher, B.G., Artigas, A., Vincent, J.L., Dmitrienko, A., Jackson, K., Thompson, B.T. & Bernard, G. (2004) Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Critical Care Medicine, 32, 1695-1702.
95. Zhou, J., Hu, L., Cui, Z., Jiang, X., Wang, G., Krissansen, G.W. & Sun, X. (2010) Interaction of SDF-1alpha and CXCR4 plays an important role in pulmonary cellular infiltration in differentiation syndrome. International Journal of Hematology, 91, 293-302.